WASHINGTON >> Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss drugs, especially those bought online, outgoing U.S. Food ...

This story was edited to include a statement from Youjin Seo, owner Laughlin Pharmacy and Wellness Center. LAUGHLIN — Two ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

The office of the U.S. Trade Representative warned that there’s a risk of ineffective or dangerous drugs from online ...

One of the biggest advantages of pharmacies is their accessibility. Located in neighborhoods and small towns, they provide an ...

CHICAGO As 2025 begins and millions of Americans start working to keep their New Year’s resolutions, Attorney General Kwame ...

Attorney General Kwame Raoul is warning Illinois residents seeking GLP-1 medications – Ozempic, Wegovy, Mounjaro, Zepbound ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...

The USA compounding pharmacies market is on track for significant growth, estimated to reach USD 5,156.2 million in 2024, ...

The FDA declined to comment. The Outsourcing Facilities Association, which brought the lawsuit along with a Texas compounding pharmacy did not immediately respond to requests for comment.